9-cis retinoic acid - A better retinoid for the modulation of differentiation, proliferation and gene expression in human neuroblastoma

Journal of Neuro-Oncology

Volumn 31, Issue 1-2, 1997, Pages 85-91

  Lovat, Penny E ^a   Irving, Helen ^a   Malcolm, Archie J ^a   Pearson, Andrew D J ^a   Redfern, Christopher P F ^a,b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

9 cis retinoic acid; Differentiation; Neuroblastoma; Proliferation; RAR; RXR

Indexed keywords

ALITRETINOIN; LG 153; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOID DERIVATIVE; RETINOID X RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; GENE INDUCTION; HUMAN; HUMAN CELL; NEUROBLASTOMA; PROGNOSIS;

BLOTTING, NORTHERN; CELL DIFFERENTIATION; CELL DIVISION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEUROBLASTOMA; RNA, MESSENGER; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0031040171     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005785431343     Document Type: Article

References (35)

1. Finklestein JZ, Krailo MD, Lenarsky C, Ladison S, Blair G, Reynolds CP, Sitarz AL, Hammond GD : 13-cis retinoic acid (NSC122758) in the treatment of children with metastatic neuroblastoma unresponsive to conventional chemotherapy: report from the Children's Cancer Study Group. Med Ped Oncol 20: 307-311, 1992
2. Smith MA, Adamson PC, Balis FM, Feusner J, Aranson L, Murphy RF, Horovitz ME, Reaman G, Denman-Hammond G, Fenton RM, Connaghan GD, Hittleman WN, Poplack DG: Phase I and pharmacokinetic evaluation of all-trans retinoic acid in pediatric patients with cancer. J Clin Oncol 10: 1666-1673, 1992
3. Sidell N: Retinoic acid-induced growth inhibition and morphologic differentiation of human neuroblastoma cells in vitro. J Natl Cancer Inst 68: 589-593, 1982
4. Amos B, Lotan R: Retinoid sensitive cells and cell lines. Meths Enzymol 190: 217-225, 1990
5. Redfern CPF: Retinoic acid receptors. Pathobiology 60: 254-263, 1992
6. Mangelsdorf DJ, Evans RM: Vitamin A receptors: new insights on retinoid control of transcription. In: Morriss-Kay, G (ed) Retinoids in Normal Development and Teratogenesis. Oxford University Press, Oxford, 1992, pp 27-50
7. Zhang X-K, Hoffmann B, Tran PBV, Graupner G, Pfahl M: Retinoid X receptor is an auxiliary protein for thyroid hormone and retinoic acid receptors. Nature 355: 441-445, 1992
8. Stunnenberg HG: Mechanisms of transactivation by retinoic acid receptors. BioEssays 15: 309-15, 1993
9. Levin A A, Sturzenbecker LJ, Kazmer S, Bosakowski T, Huselton C, Allenby G, Speck J, Kratzeisen C, Rosenberger M, Lovey A, Grippo JF: 9-cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRα. Nature 355: 359-361, 1992
10. Heyman RA, Mangelsdorf DJ, Dyck JA, Stein RB, Eichele G, Evans RM, Thaller C: 9-cis retinoic acid is a high-affinity ligand for the retinoid X receptor. Cell 68: 397-406, 1992
11. Zhang X-K, Lehmann J, Hoffmann B, Dawson MI, Cameron J, Graupner G, Hermann T, Tran P, Pfahl M: Homodimer formation of retinoid X receptor induced by 9-cis retinoic acid. Nature 358: 587-91, 1992
12. Allegretto EA, McClurg MR, Lazarchik SB, Clemm DL, Kerner SA, Elgort MF, Boehm MF, White SK, Pike JW, Heyman RA: Transactivation properties of retinoic acid and retinoid X receptors in mammalian cells and yeast-correlation with hormone binding and effects of metabolism. J Biol Chem 1993: 268: 26625-33, 1993
13. Crettaz M, Baron A, Siegenthaler G, Hunziker W: Ligand specificities of recombinant retinoic acid receptors RARα and RARβ. Biochem J 272: 391-397, 1990
14. Allenby G, Bocquel M-T, Saunders M, Kazmer S, Speck J, Rosenberger M, Lovey A, Kastner P, Grippo J, Chambon P, Levin A: Retinoic acid receptors and retinoid X receptors: Interactions with endogenous retinoic acids. Proc Natl Acad Sci USA 90: 30-34, 1993
15. Lovat PE, Lowis SP, Pearson ADJ, Malcolm AJ, Redfern CPF: Concentration-dependent effects of 9-cis retinoic acid on neuroblastoma cell differentiation and proliferation in vitro. Neurosci Lett 182: 29-32, 1994
16. Gillies RJ, Didier N, Denton M: Determination of cell number in monolayer cultures. Anal Biochem 159: 109-113, 1986
17. Hill BT, Whelan RDH: Assessments of sensitivities of cultured human neuroblastoma cells to antitumour drugs. Pediatr Res 15: 1117-1122, 1981
18. Wilkinson M: RNA isolations miniprep. Nucl Acids Res 16: 10933, 1988
19. Redfern CPF, Lovat PE, Malcolm AJ, Pearson ADJ: Differential effects of 9-cis and all-trans retinoic acid on the induction of retinoic acid receptor-β and cellular retinoic acid binding protein II in human neuroblastoma cells. Biochem J 304: 147-154, 1994
20. Kizaki M, Nakajima H, Mori S, Koike T, Morikawa M, Ohta M, Saito M, Koeffler HP, Ikeda Y: Novel retinoic acid, 9-cis retinoic acid, in combination with all-trans retinoic acid is an effective inducer of differentiation of retinoic acid resistant HL-60 cells. Blood 83: 3289-3297, 1994
21. Lovat PE, Pearson ADJ, Malcolm AJ, Redfern CPF: Retinoic acid receptor expression during the in vitro differentiation of human neuroblastoma. Neurosci Lett 162: 109-113, 1993
22. Clagett-Dame M, Verhalen TJ, Biedler JL, Repa JJ: Identification and characterization of all-trans retinoic acid receptor transcripts and receptor protein in human neuroblastoma cells. Arch Biochem Biophys 300: 684-693, 1993
23. Xu X-C, Ro JY, Lee JS, Shin DM, Hong WK, Lotan R: Differential expression of nuclear retinoid receptors in normal, premalignant, and malignant head and neck tissues. Cancer Res 54: 3580-87, 1994
24. Haber M, Madafiglio J, Bordow SB, Gilbert J, Bellamy C, Marshall GM, Norris MD: Expression of retinoic acid-responsive genes in primary neuroblastoma. Adv Neuroblastoma Res 4: 245-251, 1994
25. Boehm MF, Zhang L, Badea BA, White SK, Mais DE, Berger E, Suto CM, Goldman ME, Heyman RA: Synthesis and structure-activity relationships of novel retinoid X receptor-selective retinoids. J Med Chem 37: 2930-2941, 1994
26. Houle B, Rochette-Egly C, Bradley WEC: Tumor-supressive effect of the retinoic acid receptor β in human epidermoid lung cancer cells. Proc Natl A cad Sci U SA 90: 985-989, 1993
27. Anzano MA, Byers SW, Smith JM, Peer CW, Mullen LT, Brown CC, Roberts AB, Sporn MB: Prevention of breast cancer in the rat with 9-cis-retinoic acid as a single agent and in combination with tamoxifen. Cancer Res 54: 4614-4617, 1994
28. Adamson PC, Murphy RF, Godwin KA, Ulm EH, Balis FM: Pharmacokinetics of 9-cis retinoic acid in the rhesus monkey. Cancer Res 55: 482-485, 1995
29. Fogh K, Voorhees JJ, Åström A: Expression, purification, and binding properties of human cellular retinoic acid binding protein type I and type II. Arch Biochem Biophys 300: 751-755, 1993
30. Redfern CPF, Wilson KE: Ligand binding properties of human cellular retinoic acid binding protein II expressed in E.coli as a glutathione-S-transferase fusion protein. FEBS Lett 321: 163-168, 1993
31. Boylan JF, Gudas LJ: Overexpression of the cellular retinoic acid binding protein-I (CRABP-I) results in a reduction in differentiation-specific gene expression in F9 teratocarcinoma cells. J Cell Biol 112: 965-979, 1991
32. Napoli JL: Biosynthesis and metabolism of retinoic acid: Roles of CRBP and CRABP in retinoic acid homeostasis. J Nutr 123: 362-366, 1993
33. Redfern CPF, Lovat PE, Malcolm AJ, Pearson ADJ: Gene expression and neuroblastoma cell differentiation in response to retinoic acid: differential effects of 9-cis and all-trans retinoic acid. Eur J Cancer 31A: 486-494, 1995
34. Cornic M, Delva L, Castaigne S, Lefebvre P, Balitrand N, Degos L, Chomienne, C: In vitro all-trans retinoic acid (ATRA) sensitivity and cellular retinoic acid binding protein (CRABP) levels in relapse leukemic cells after remission induction by ATRA in acute promyelocytic leukemia. Leukaemia 8 (suppl. 2): S16-19, 1994
35. Kurie JM, Lippman SM, Hong WK: Potential of retinoids in cancer prevention. Cancer Treat Rev 20: 1-10, 1994